Using continuous glucose monitoring to predict outcomes in acute coronary syndrome

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the predictive value of glycemic parameters measured with the Freestyle Libre Pro iQ device in patients hospitalized for acute coronary syndrome (ACS). It focuses on understanding how glycemic variability and hyperglycemia can influence short- and long-term cardiovascular events. The study aims to enroll patients diagnosed with ACS in a cardiac intensive care unit and will analyze their glucose levels to identify potential prognostic indicators. By utilizing continuous glucose monitoring, the research seeks to improve risk stratification and management of ACS patients.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients with ACS managed in a cardiac intensive care unit (ICU). The diagnosis of ACS will be made in the presence of chest pain with ST-segment elevation on the ECG for STEMI or ST-segment change and/or a positive troponin cycle (values in accordance with the center's protocol) for NSTEMI.

Exclusion Criteria:

* Subjects in cardiogenic or septic shock
* Subjects with ACS initially managed in a non-investigating center
* Failure to obtain free, informed, written consent signed by the participant and investigator upon admission to the ICU
* Person participating in another research study with an ongoing exclusion period
* Subjects participating in a study that may have an impact on post ACS prognosis
* Person deprived of his or her rights, person under guardianship or curatorship
* Person deprived of liberty (by judicial or administrative decision)
* Persons whose physical and/or psychological health is severely impaired, which, in the opinion of the investigator, may affect the participant's compliance to the study
* Pregnant or breastfeeding women
* Person who is not affiliated to a social security system or who is a beneficiary of such a system.

Where it's running

• Hospital of Béziers
  Béziers, France Recruiting
• University Hospital of Bordeaux
  Bordeaux, France Recruiting
• University Hospital of Montpellier
  Montpellier, France Recruiting
• University Hospital of Nîmes
  Nîmes, France Recruiting
• AP-HP Lariboisière Hospital
  Paris, France Recruiting
• APHP - Hôpital Européen Georges Pompidou
  Paris, France Recruiting

Study contacts

• Study coordinator: Ariane SULTAN, Professor
• Email: a-sultan@chu-montpellier.fr
• Phone: 0467338431

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Common femoral vein-to-artery diameter ratio to detect elevated LVEDP

  Researchers test whether the ratio of the common femoral vein to artery diameters, measured by ultrasound, can flag elevated LV end-diastolic pressure in patients having coronary angiography.

  Recruiting Burapha University · Chon Buri · NCT07866859

• Predictive CGM with App for people with type 1 or insulin-treated type 2 diabetes

  This study tests whether using the Accu-Chek SmartGuide CGM with its Predict App can reduce fear of hypoglycemia and improve related behaviors and confidence in adults with type 1 or insulin-treated type 2 diabetes.

  Recruiting Fidam Rdc · Bad Mergentheim, Baden-Wurttemberg · NCT07814508

• Intrahospital flu vaccine for adults with high cardiovascular risk when admitted for ACS or heart failure

  This study tests whether offering a flu vaccine at the bedside during a hospital stay, along with counseling, increases vaccination rates for adults with acute coronary syndrome or heart failure who are at high cardiovascular risk.

  Recruiting at 2 sites University Hospital of Cologne · Cologne and 1 other locations · NCT07721649

• Digital lifestyle platform after rehabilitation to support self-management

  A digital, patient-facing platform is being tested to see if people who recently finished inpatient rehabilitation will use it and benefit from personalized lifestyle guidance at home.

  Recruiting at 2 sites Insel Gruppe AG, University Hospital Bern · Bern, Canton of Bern and 1 other locations · NCT07597031

• AI-driven Medipixel fractional flow reserve to guide PCI

  This test checks whether an AI-based, angiography-derived Medipixel FFR method can guide PCI as safely and effectively as standard invasive pressure-wire FFR in adults with coronary artery disease.

  Recruiting at 23 sites Samsung Medical Center · Seoul, Select State and 22 other locations · NCT07329699

• Freesolve resorbable magnesium scaffold vs. Xience stent for up to two new heart artery lesions

  This trial tests whether the Freesolve resorbable magnesium scaffold works as well as the Xience drug-eluting stent for treating up to two new coronary artery lesions in adults.

  Recruiting at 3 sites Teleflex · Washington D.C., District of Columbia and 2 other locations · NCT07258290

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.